DE60123074D1 - MODULATION OF GAMMA-SECRETASE ACTIVITY - Google Patents

MODULATION OF GAMMA-SECRETASE ACTIVITY

Info

Publication number
DE60123074D1
DE60123074D1 DE60123074T DE60123074T DE60123074D1 DE 60123074 D1 DE60123074 D1 DE 60123074D1 DE 60123074 T DE60123074 T DE 60123074T DE 60123074 T DE60123074 T DE 60123074T DE 60123074 D1 DE60123074 D1 DE 60123074D1
Authority
DE
Germany
Prior art keywords
app
gamma
secretase
assay
cells expressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60123074T
Other languages
German (de)
Other versions
DE60123074T3 (en
DE60123074T2 (en
Inventor
Barbara Cordell
N Higaki
Mitchell Mutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scios LLC
Original Assignee
Scios LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22754280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60123074(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scios LLC filed Critical Scios LLC
Application granted granted Critical
Publication of DE60123074D1 publication Critical patent/DE60123074D1/en
Publication of DE60123074T2 publication Critical patent/DE60123074T2/en
Publication of DE60123074T3 publication Critical patent/DE60123074T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Holo Graphy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides cell-free gamma-secretase activity. The method of the invention utilizes a membrane source of APP/gamma-secretase mixture in the assay to determine factors that may enhance or decrease enzymatic activity affecting beta-amyloid peptide production. The cell membranes used in the assay may be from cells expressing an endogenous APP or, preferably, cells expressing a recombinant APP. The APP may be full-length or a fragment capable of being proteolytically cleaved by gamma-secretase. In addition, the APP expressed in the cells may have one or more mutation, such as a point mutation, small deletion, etc.
DE60123074.4T 2000-05-11 2001-05-09 MODULATION OF GAMMA SECRETASE ACTIVITY Expired - Lifetime DE60123074T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20350600P 2000-05-11 2000-05-11
US203506P 2000-05-11
EP01935260.8A EP1305406B2 (en) 2000-05-11 2001-05-09 Modulation of gamma-secretase activity
PCT/US2001/015089 WO2001085924A2 (en) 2000-05-11 2001-05-09 MODULATION OF η-SECRETASE ACTIVITY

Publications (3)

Publication Number Publication Date
DE60123074D1 true DE60123074D1 (en) 2006-10-26
DE60123074T2 DE60123074T2 (en) 2007-03-01
DE60123074T3 DE60123074T3 (en) 2015-01-29

Family

ID=22754280

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123074.4T Expired - Lifetime DE60123074T3 (en) 2000-05-11 2001-05-09 MODULATION OF GAMMA SECRETASE ACTIVITY

Country Status (8)

Country Link
US (2) US6579689B2 (en)
EP (1) EP1305406B2 (en)
JP (1) JP2003532413A (en)
AT (1) ATE339496T1 (en)
AU (1) AU2001261368A1 (en)
DE (1) DE60123074T3 (en)
DK (1) DK1305406T4 (en)
WO (1) WO2001085924A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075435A2 (en) * 2000-04-03 2001-10-11 Bristol-Myers Squibb Company Fluorescence assay for gamma-secretase activity and inhibitors
US20030022251A1 (en) * 2001-07-04 2003-01-30 Boehringer Ingelheim Pharma Kg Gamma-secretase in vitro screening assay
US7910586B2 (en) 2002-01-04 2011-03-22 The Rockefeller University Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
CN1319987C (en) * 2002-04-24 2007-06-06 森启 Gamma-secretase inhibitors
AU2006203819A1 (en) * 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
WO2011016861A2 (en) 2009-08-05 2011-02-10 Intra-Cellular Therapies, Inc. Novel regulatory proteins and inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372888A (en) † 1980-08-26 1983-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Nondenaturing zwitterionic detergents
CA2191924A1 (en) * 1995-12-05 1997-06-06 Kevin Felsenstein 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production
GB9608657D0 (en) * 1996-04-26 1996-07-03 Smithkline Beecham Plc Novel treatment
WO1998015828A1 (en) 1996-10-07 1998-04-16 Scios Inc. Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase
US6313268B1 (en) † 1998-10-16 2001-11-06 Vivian Y. H. Hook Secretases related to Alzheimer's dementia
DE19941039A1 (en) * 1999-08-28 2001-03-01 Boehringer Ingelheim Pharma gamma-secretase in vitro test system
DE10000161A1 (en) * 2000-01-06 2001-07-19 Boehringer Ingelheim Pharma Determining test substances that inhibit protease, involves incubating cells expressing fusion protein having substrate with cleavage site for protease and reporter, measuring cleaved reporter and comparing with standard
WO2001075435A2 (en) * 2000-04-03 2001-10-11 Bristol-Myers Squibb Company Fluorescence assay for gamma-secretase activity and inhibitors

Also Published As

Publication number Publication date
US20010055782A1 (en) 2001-12-27
DK1305406T4 (en) 2015-02-02
AU2001261368A1 (en) 2001-11-20
DE60123074T3 (en) 2015-01-29
DE60123074T2 (en) 2007-03-01
US20030211559A1 (en) 2003-11-13
EP1305406B2 (en) 2014-11-12
WO2001085924A3 (en) 2003-02-27
EP1305406B1 (en) 2006-09-13
JP2003532413A (en) 2003-11-05
DK1305406T3 (en) 2007-01-08
ATE339496T1 (en) 2006-10-15
EP1305406A2 (en) 2003-05-02
US6579689B2 (en) 2003-06-17
WO2001085924A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
DK1210411T3 (en) Compositions and Methods for Improved Cell Culture
HUP0301245A2 (en) Tmethod for the production of vitamin k-dependent proteins
DE69634640D1 (en) MUTATED ALPHA-AMYLASE ENZYME WITH INCREASED STABILITY
ATE450635T1 (en) ELECTROCHEMICAL PRODUCTION OF PEROXODISULFURIC ACID USING DIAMOND-COATED ELECTRODES
Fox et al. Identification of potential activators of proteinase‐activated receptor‐2 1
IL150168A0 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
BR0009362A (en) Variant of an alpha-amylase similar to atherma precursor, DNA construction, recombinant expression vector, cell, composition, process to generate a variant of an alpha-amylase similar to precursor termamyl, and, use of an alpha-amylase variant
WO2001016285A3 (en) Novel proteases and variants thereof
DK1280898T3 (en) Modified ES cells and ES cell specific gene
ATE500323T1 (en) SUBTILISIN VARIANT
ATE437652T1 (en) USE OF HMGB1 TO ACTIVATE DENDRITIC CELLS
DK1266011T3 (en) Fungal transcription activator useful in methods of producing polypeptides
HUP0301356A2 (en) Novel serine protease genes related to dppiv
DE59903410D1 (en) HYBRID PROTEIN TO INHIBIT MAST CELL DEGRANULATION AND USE
DE60232234D1 (en) METHOD OF CULTURING CIRCOVIRUS
DK1117798T3 (en) Fungal transcriptional activator suitable for polypeptide production methods
DE60123074D1 (en) MODULATION OF GAMMA-SECRETASE ACTIVITY
WO2004011637A3 (en) Modified adamts4 molecules and method of use thereof
DK0866848T3 (en) Enhanced neurospora hosts for the production of recombinant proteins and methods for producing the same
TR200000288T2 (en) Recombinant expression of the insulin C-peptide.
AU7843101A (en) Furin polypeptides with improved characteristics
DE60235985D1 (en) NTB-A, A SURFACE MOLECULE IMPLIED IN THE ACTIVITY OF NATURAL KILLER CELLS (NK)
WO2003021265A8 (en) Genetic construct intracellular monitoring system
GB9720693D0 (en) Assay
ATE334592T1 (en) BIOLOGICAL CONTROL OF NEMATODES

Legal Events

Date Code Title Description
8363 Opposition against the patent